Stanmax Laboratories Profile
Key Indicators
- Authorised Capital ₹ 2.60 Cr
as on 17-11-2024
- Paid Up Capital ₹ 8.00 M
as on 17-11-2024
- Company Age 28 Year, 1 Month
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 2.35 Cr
as on 17-11-2024
- Revenue -24.44%
(FY 2023)
- Profit 118.89%
(FY 2023)
- Ebitda 83.54%
(FY 2023)
- Net Worth 7.92%
(FY 2023)
- Total Assets 54.86%
(FY 2023)
About Stanmax Laboratories
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.60 Cr and a paid-up capital of Rs 8.00 M.
The company currently has active open charges totaling ₹2.35 Cr.
Ghanukota Rupa and Ghanukota Kumar serve as directors at the Company.
- CIN/LLPIN
U24235TG1996PTC025837
- Company No.
025837
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
02 Dec 1996
- Date of AGM
26 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Stanmax Laboratories?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ghanukota Rupa  | Director | 04-Apr-2007 | Current |
| Ghanukota Kumar | Director | 28-Mar-2018 | Current |
Financial Performance of Stanmax Laboratories.
Stanmax Laboratories Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 24.44% decrease. The company also saw a substantial improvement in profitability, with a 118.89% increase in profit. The company's net worth moved up by a moderate rise of 7.92%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Stanmax Laboratories?
In 2023, Stanmax Laboratories had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Axis Bank Limited Creation Date: 25 May 2021 | ₹1.00 Cr | Open |
Hdfc Bank Limited Creation Date: 27 Nov 2015 | ₹5.00 M | Open |
Indusind Bank Limited Creation Date: 29 Sep 2014 | ₹5.50 M | Open |
How Many Employees Work at Stanmax Laboratories?
Stanmax Laboratories has a workforce of 27 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Stanmax Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Stanmax Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
